RxSight I, LLC - 03 Aug 2021 Form 4 Insider Report for RxSight, Inc. (RXST)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Aug 2021, 19:52:41 UTC
Prior SEC filing
29 Jul 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ William Link, Manager

Key filing fact

RxSight I, LLC filed Form 4 for RxSight, Inc. (RXST) on 05 Aug 2021.

Key facts

  • This page summarizes RxSight I, LLC's Form 4 filing for RxSight, Inc. (RXST).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Aug 2021, 19:52.

Change

  • Previous filing in this sequence was filed on 29 Jul 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXST transaction

Common Stock

Conversion of derivative security

Transaction value
$0
Shares
+2,016,778
Change %
Price
$0.000000
Shares after
2,016,778
Date
03 Aug 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST transaction Derivative

Series H Preferred Stock

Conversion of derivative security

Transaction value
$0
Shares
-2,016,778
Change %
-100%
Price
$0.000000*
Shares after
0
Date
03 Aug 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,016,778
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

RxSight I, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .